Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: SIMCERE PHARMA(02096) the Revenue is 2.643 B (+34.72%);the EBIT is 601.3 M (+54.34%);the EPS is 0.185 (+37.2%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
2.64B34.72%
----
----
EBIT
0.60B54.34%
----
----
EPS
0.184737.20%
----
----
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf